Thomas G. Brott

Q: What Schools Are Affiliated With Thomas G. Brott

Thomas G. Brott is affiliated with the following schools: University of Alabama at Birmingham, Université Laval, University of Calgary, University of Cincinnati, Wake Forest University, University of Michigan, Medical University of Innsbruck, University of California, Los Angeles, Cornell University, University of Toronto, University of Virginia, University of Iowa, Massachusetts General Hospital, University College London, Medical University of South Carolina, Georgetown University

Thomas G. Brott's AcademicInfluence.com Rankings

Thomas G. Brott

Medical

#1388

World Rank

#1721

Historical Rank

Neurology

#123

World Rank

#185

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Thomas G. Brott Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Thomas G. Brott's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. (1995) (8951)
Measurements of acute cerebral infarction: a clinical examination scale. (1989) (4735)
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials (2004) (2577)
Stenting versus endarterectomy for treatment of carotid-artery stenosis. (2010) (2093)
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials (2010) (1958)
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials (2014) (1828)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1784)
The ABCs of measuring intracerebral hemorrhage volumes. (1996) (1776)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1700)
Volume of Intracerebral Hemorrhage: A Powerful and Easy‐to‐Use Predictor of 30‐Day Mortality (1993) (1548)
Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association (2003) (1319)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1192)
Improved Reliability of the NIH Stroke Scale Using Video Training (1994) (1117)
Early hemorrhage growth in patients with intracerebral hemorrhage. (1997) (1098)
The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. (1998) (758)
Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. (1996) (709)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). (2012) (642)
Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. (1999) (641)
Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. (1998) (624)
Cincinnati Prehospital Stroke Scale: reproducibility and validity. (1999) (591)
Initial and Recurrent Bleeding Are the Major Causes of Death Following Subarachnoid Hemorrhage (1994) (572)
Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes (1992) (569)
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideline (2011) (559)
Effects of tissue plasminogen activator for acute ischemic stroke at one year (1999) (555)
Phenylpropanolamine and the risk of hemorrhagic stroke. (2000) (552)
Public perception of stroke warning signs and knowledge of potential risk factors. (1998) (548)
Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. (1993) (543)
Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. (2004) (542)
Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. (1994) (522)
Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. (1995) (506)
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial (2002) (496)
The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. (1992) (443)
Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. (1995) (441)
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideline (2011) (441)
Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. (1996) (432)
Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. (1998) (420)
Early stroke treatment associated with better outcome The NINDS rt-PA Stroke Study (2000) (398)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (388)
Measurements of acute cerebral infarction: lesion size by computed tomography. (1989) (376)
Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. (2001) (375)
Early stroke treatment associated with better outcome: the ninds rt-pa stroke study (2000) (371)
Hypertension as a risk factor for spontaneous intracerebral hemorrhage. (1986) (366)
Urgent Therapy for Stroke: Part II. Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes From Onset (1992) (366)
Recommendations for the management of patients with unruptured intracranial aneurysms: A statement for healthcare professionals from the Stroke Council of the American Heart Association. (2000) (345)
Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis. (2016) (340)
Patients' awareness of stroke signs, symptoms, and risk factors. (1997) (338)
Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. (1998) (332)
The Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST): Stenting Versus Carotid Endarterectomy for Carotid Disease (2010) (329)
Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. (1996) (322)
Stroke in Children Within a Major Metropolitan Area: The Surprising Importance of Intracerebral Hemorrhage (1993) (321)
Relative Edema Volume Is a Predictor of Outcome in Patients With Hyperacute Spontaneous Intracerebral Hemorrhage (2002) (317)
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke (1998) (314)
Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. (1999) (306)
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. (2011) (301)
Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators. (1999) (294)
Diagnosis and management of neurological sarcoidosis. (1997) (294)
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. (2011) (288)
Safety of Stenting and Endarterectomy by Symptomatic Status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) (2011) (288)
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. (1999) (280)
A Modified National Institutes of Health Stroke Scale for Use in Stroke Clinical Trials: Preliminary Reliability and Validity (2001) (277)
Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. (1999) (260)
Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. (1997) (258)
Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial (2012) (255)
Treatment of acute ischemic stroke. (2000) (253)
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American (2011) (253)
Acute stroke: delays to presentation and emergency department evaluation. (1999) (251)
Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. (1996) (251)
Ultra-early evaluation of intracerebral hemorrhage. (1990) (248)
Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. (1996) (239)
Recommendations for the Management of Patients With Unruptured Intracranial Aneurysms: A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association (2000) (230)
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. (1999) (225)
Hypertension and its treatment in the NINDS rt-PA Stroke Trial. (1998) (221)
Natural History of Perihematomal Edema in Patients With Hyperacute Spontaneous Intracerebral Hemorrhage (2002) (220)
Factors Related to Intracranial Hematoma Formation in Patients Receiving Tissue‐Type Plasminogen Activator forAcute Ischemic Stroke (1994) (216)
Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group. (1999) (210)
A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release (2007) (207)
Long-Term Results of Stenting Versus Endarterectomy for Carotid-Artery Stenosis. (2016) (206)
The Practice of Carotid Endarterectomy In A Large Metropolitan Area (1984) (202)
Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) (2011) (199)
Predicting prognosis after stroke (2000) (198)
Age and Outcomes After Carotid Stenting and Endarterectomy: The Carotid Revascularization Endarterectomy Versus Stenting Trial (2011) (197)
Time of hospital presentation in patients with acute stroke. (1993) (195)
Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. (2004) (194)
Clinical Deterioration Following Improvement in the NINDS rt-PA Stroke Trial (2001) (193)
Frequency and accuracy of prehospital diagnosis of acute stroke. (1995) (193)
Myocardial Infarction After Carotid Stenting and Endarterectomy: Results From the Carotid Revascularization Endarterectomy Versus Stenting Trial (2011) (186)
Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data (2018) (183)
The Carotid Revascularization Endarterectomy versus Stenting Trial: credentialing of interventionalists and final results of lead-in phase. (2010) (181)
Major Risk Factors for Aneurysmal Subarachnoid Hemorrhage in the Young Are Modifiable (2003) (179)
Early stroke recognition: developing an out-of-hospital NIH Stroke Scale. (1997) (178)
Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group. (1993) (172)
Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials (2016) (167)
Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. (1999) (166)
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive summary (2011) (162)
Major Risk Factors for Intracerebral Hemorrhage in the Young Are Modifiable (2005) (158)
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis (2016) (158)
Common variants at 6p21.1 are associated with large artery atherosclerotic stroke (2012) (156)
Stroke After Carotid Stenting and Endarterectomy in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) (2012) (156)
The Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke: The CLEAR Stroke Trial (2008) (153)
Update in Intracerebral Hemorrhage (2011) (150)
Verifying the stroke-free phenotype by structured telephone interview. (2000) (148)
Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). (2011) (145)
Baseline Silent Cerebral Infarction in the Asymptomatic Carotid Atherosclerosis Study (1994) (144)
White matter hyperintensity volume is increased in small vessel stroke subtypes (2010) (144)
Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials (2017) (140)
Lack of Evidence for an Association Between Hemodynamic Variables and Hematoma Growth in Spontaneous Intracerebral Hemorrhage (2006) (137)
Finding the Most Powerful Measures of the Effectiveness of Tissue Plasminogen Activator in the NINDS tPA Stroke Trial (2000) (131)
Lobar Hemorrhage in the Elderly: The Undiminishing Importance of Hypertension (1993) (131)
Vascular Cell Senescence Contributes to Blood–Brain Barrier Breakdown (2016) (131)
Phosphodiesterase 4D and 5‐lipoxygenase activating protein in ischemic stroke (2005) (125)
Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study. (1999) (124)
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary (2011) (123)
Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study. (2014) (121)
The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. (2005) (116)
Approval of the MERCI clot retriever: a critical view. (2005) (115)
Urgent Therapy for Acute Stroke: Effects of a Stroke Trial on Untreated Patients (1994) (114)
Validity of Claims-Based Stroke Algorithms in Contemporary Medicare Data: Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study Linked With Medicare Claims (2014) (112)
Blood pressure during the first minutes of focal cerebral ischemia. (1993) (111)
Credentialing of surgeons as interventionalists for carotid artery stenting: experience from the lead-in phase of CREST. (2004) (110)
Management of intracerebral hemorrhage in a large metropolitan population. (1994) (107)
Design of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) (2010) (105)
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile (2006) (103)
Hyperdense middle cerebral artery sign on CT: efficacy in detecting middle cerebral artery thrombosis. (1990) (103)
CREST: carotid revascularization endarterectomy versus stent trial. (1997) (102)
Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhage. (2000) (97)
Changing patterns in the practice of carotid endarterectomy in a large metropolitan area. (1986) (94)
The Siblings With Ischemic Stroke Study (SWISS) Protocol (2002) (91)
Recombinant tissue plasminogen activator for minor strokes: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience (2005) (91)
Hyperglycemia and hemorrhagic transformation of cerebral infarcts. (1995) (90)
Carotid Endarterectomy and Carotid Artery Stenting in the US Medicare Population, 1999-2014 (2017) (87)
Thrombus localization with emergency cerebral CT. (1992) (82)
The influence of surgical specialty and caseload on the results of carotid endarterectomy. (1986) (82)
Emerging therapies for acute ischemic stroke: new therapies on trial. (2003) (80)
Intensive care for acute stroke in the community hospital setting. The first 24 hours. (1989) (76)
Prestroke physical activity and early functional status after stroke (2009) (73)
Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke. (2007) (73)
Emergency physicians. Accuracy in the diagnosis of stroke. (1995) (72)
Costs and Cost-Effectiveness of Carotid Stenting Versus Endarterectomy for Patients at Standard Surgical Risk: Results From the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) (2012) (70)
Early Endarterectomy Carries a Lower Procedural Risk Than Early Stenting in Patients With Symptomatic Stenosis of the Internal Carotid Artery: Results From 4 Randomized Controlled Trials (2017) (66)
Use of Ephedra-containing products and risk for hemorrhagic stroke (2003) (66)
Outcomes after carotid artery stenting in Medicare beneficiaries, 2005 to 2009. (2015) (64)
The Ischemic Stroke Genetics Study (ISGS) Protocol (2003) (63)
A dose-escalation study of large doses of naloxone for treatment of patients with acute cerebral ischemia. (1986) (62)
Computer-Assisted Volumetric Analysis Compared With ABC/2 Method for Assessing Warfarin-Related Intracranial Hemorrhage Volumes (2008) (62)
Interobserver agreement in the trial of org 10172 in acute stroke treatment classification of stroke based on retrospective medical record review. (2006) (61)
Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis: a preplanned pooled analysis of individual patient data (2019) (60)
Does Sex Matter? Thirty-Day Stroke and Death Rates After Carotid Artery Stenting in Women Versus Men: Results From the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) Lead-in Phase (2009) (59)
High-dose intravenous naloxone for the treatment of acute ischemic stroke. (1990) (59)
Mechanism of mesenchymal stem cell-induced neuron recovery and anti-inflammation. (2014) (59)
Hyperdense middle cerebral artery: incidence and quantitative significance (2004) (58)
Early treatment for acute ischemic stroke. (1989) (57)
Aging blunts ischemic-preconditioning-induced neuroprotection following transient global ischemia in rats. (2005) (57)
Organizing the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): National Institutes of Health, Health Care Financing Administration, and industry funding (2001) (55)
Ischaemic stroke (2018) (54)
Pilot Randomized Trial of Tissue Plasminogen Activator in Acute Ischemic Stroke (1993) (54)
Differential outcomes of carotid stenting and endarterectomy performed exclusively by vascular surgeons in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). (2013) (53)
Enhancing recovery after acute ischemic stroke with donepezil as an adjuvant therapy to standard medical care: results of a phase IIA clinical trial. (2011) (51)
Reliability of the Questionnaire for Verifying Stroke-Free Status (2003) (51)
Candidate Gene Polymorphisms for Ischemic Stroke (2009) (51)
Incidence, outcomes, and effect on quality of life of cranial nerve injury in the Carotid Revascularization Endarterectomy versus Stenting Trial. (2015) (50)
Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke (2001) (50)
Preserved color imagery in an achromatopsic (1996) (50)
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/ SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary (2011) (50)
Use of ancrod in acute or progressing ischemic cerebral infarction. (1988) (49)
Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. (1994) (47)
Time From Symptoms to Carotid Endarterectomy or Stenting and Perioperative Risk (2015) (47)
Thrombolytic therapy in cerebrovascular disorders. (1992) (47)
Anesthetic type and risk of myocardial infarction after carotid endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). (2015) (47)
Effect of Patching on Reducing Restenosis in the Carotid Revascularization Endarterectomy Versus Stenting Trial (2015) (46)
Management of Intracerebral Hemorrhage in a Large Metropolitan Population (1994) (46)
Carotid angiographic characteristics in the CREST trial were major contributors to periprocedural stroke and death differences between carotid artery stenting and carotid endarterectomy. (2016) (46)
The Carotid Revascularization Endarterectomy vs. Stenting Trial completes randomization: lessons learned and anticipated results. (2009) (45)
Asymmetric angioneurotic edema associated with thrombolysis for acute stroke. (1997) (45)
Intracerebral hemorrhage volume measurement. (1994) (43)
3-D image analysis of intra-cerebral brain hemorrhage from digitized CT films. (1995) (43)
Genetics of cerebrovascular disorders. (2005) (42)
Carotid revascularization for prevention of stroke: carotid endarterectomy and carotid artery stenting. (2004) (42)
Use of high dose naloxone in acute stroke: possible side-effects. (1989) (42)
Spanish cross-cultural adaptation and validation of the National Institutes of Health Stroke Scale. (2006) (42)
Thrombolytic Therapy for Stroke (2001) (42)
Comparison of admission serum glucose concentration with neurologic outcome in acute cerebral infarction. A study in patients given naloxone. (1988) (41)
Quantitative intracerebral brain hemorrhage analysis (1999) (41)
Evaluation and Management of Atherosclerotic Carotid Stenosis (2017) (40)
Medical Compared with Surgical Treatment of Asymptomatic Carotid Artery Stenosis (1995) (40)
Common mitochondrial sequence variants in ischemic stroke (2011) (39)
Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research (2005) (39)
Identification and entry of the patient with acute cerebral infarction. (1988) (39)
Brain injury after cardiopulmonary arrest and its assessment with diffusion-weighted magnetic resonance imaging. (2007) (38)
Frequency and patterns of abnormality detected by iodine-123 amine emission CT after cerebral infarction. (1986) (38)
Structural genomic variation in ischemic stroke (2008) (38)
Greater Cincinnati/Northern Kentucky Stroke Study: Volume of First-Ever Ischemic Stroke Among Blacks in a Population-Based Study (2001) (37)
Safety and Efficacy of Intraventricular Delivery of Bone Marrow-Derived Mesenchymal Stem Cells in Hemorrhagic Stroke Model (2019) (37)
Intravenous thrombolysis for acute stroke (1997) (36)
Cardiopulmonary resuscitation and emergency cardiovascular care. Stroke. (2001) (35)
Siblings With Ischemic Stroke Study: Results of a Genome-Wide Scan for Stroke Loci (2011) (35)
NOTCH3 Variants and Risk of Ischemic Stroke (2013) (35)
Are Myocardial Infarction–Associated Single-Nucleotide Polymorphisms Associated With Ischemic Stroke? (2012) (35)
Plasma neurofilament light predicts mortality in patients with stroke (2020) (34)
Treatment of the neuroleptic malignant syndrome with bromocriptine. (1983) (33)
Feasibility, safety, and changes in systolic blood pressure associated with endovascular revascularization of symptomatic and chronically occluded cervical internal carotid artery using a newly suggested radiographic classification of chronically occluded cervical internal carotid artery: pilot stud (2019) (33)
Common Variants Within Oxidative Phosphorylation Genes Influence Risk of Ischemic Stroke and Intracerebral Hemorrhage (2013) (33)
Thrombolytic therapy for stroke (1994) (32)
The investigational use of tPA for stroke. (1988) (32)
Case-control study of clinical outcome after aneurysmal subarachnoid hemorrhage. (1986) (32)
Collateral Recruitment Is Impaired by Cerebral Small Vessel Disease (2020) (31)
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials (2018) (31)
Clinical stroke trials: guarding against bias. (1999) (31)
IL1RN VNTR Polymorphism in Ischemic Stroke: Analysis in 3 Populations (2007) (31)
Genome-Wide Association Analysis of Ischemic Stroke in Young Adults (2011) (31)
Feasibility of an Affected Sibling Pair Study in Ischemic Stroke: Results of a 2-Center Family History Registry (2001) (31)
Stroke Caused by Extracranial Disease (2017) (30)
Genetic variants associated with myocardial infarction in the PSMA6 gene and Chr9p21 are also associated with ischaemic stroke (2013) (30)
Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes (2018) (29)
Carotid stenting vs endarterectomy: new results in perspective. (2010) (29)
Impact of SAMMPRIS on the future of intracranial atherosclerotic disease management: polling results from the ICAD symposium at the International Stroke Conference (2013) (28)
Carotid revascularization and medical management for asymptomatic carotid stenosis – Hemodynamics (CREST-H): Study design and rationale (2018) (27)
Carotid artery stenting: meeting the recruitment challenge of a clinical trial. (2005) (27)
Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onset. (2001) (27)
Asymptomatic carotid stenosis: What we can learn from the next generation of randomized clinical trials (2014) (26)
Evaluation of subclinical cerebral injury and neuropsychologic function in patients undergoing carotid endarterectomy. (2008) (26)
Clinical need, design, and goals for the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis trial. (2017) (26)
Thrombolytic treatment of acute ischemic stroke. (2002) (26)
Immediate and Delayed Procedural Stroke or Death in Stenting Versus Endarterectomy for Symptomatic Carotid Stenosis (2018) (24)
Research priority setting: a summary of the 2012 NINDS Stroke Planning Meeting Report. (2013) (24)
Adult choroidal vein of Galen malformation. (1995) (23)
Lack of aggregation of ischemic stroke subtypes within affected sibling pairs (2007) (23)
Imaging in StrokeNet: Realizing the Potential of Big Data (2015) (23)
Family history of stroke and severity of neurologic deficit after stroke (2006) (23)
Mediators of the Age Effect in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) (2015) (23)
Association of Integrin α2 Gene Variants with Ischemic Stroke (2008) (23)
Capgras' syndrome following minor head trauma. (1989) (22)
Thrombolysis for stroke. (1996) (22)
Rethinking Training and Distribution of Vascular Neurology Interventionists in the Era of Thrombectomy. (2017) (22)
Therapeutic Potential of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Acute Ischaemic Stroke (2004) (21)
Temporal trends in safety of carotid endarterectomy in asymptomatic patients: Systematic review (2016) (21)
Severity of White Matter Hyperintensities and Effects on All‐Cause Mortality in the Mayo Clinic Florida Familial Cerebrovascular Diseases Registry (2019) (21)
Diagnosis and invasive management of carotid atherosclerotic stenosis. (2007) (21)
Association of integrin alpha2 gene variants with ischemic stroke. (2008) (21)
National Institutes of Health Stroke Scale (2016) (19)
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American (2011) (19)
Familial Clustering of Stroke According to Proband Age at Onset of Presenting Ischemic Stroke (2003) (19)
Aging is neuroprotective during global ischemia but leads to increased caspase-3 and apoptotic activity in hippocampal neurons. (2006) (19)
General Therapy of Acute Ischemic Stroke (1994) (19)
Stroke patient evaluation in the emergency department before pharmacologic therapy. (1989) (18)
Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography. (2008) (18)
Relationship Between Physician and Hospital Procedure Volume and Mortality After Carotid Artery Stenting Among Medicare Beneficiaries (2015) (18)
Comparative Effectiveness of Carotid Artery Stenting Versus Carotid Endarterectomy Among Medicare Beneficiaries (2016) (18)
Complication Rates and Center Enrollment Volume in the Carotid Revascularization Endarterectomy Versus Stenting Trial (2014) (18)
Advances in the care of patients with intracerebral hemorrhage. (2007) (18)
Overview of hemostasis and thrombosis. (1991) (17)
Thrombolysis in patients with transient neurologic deficits (2001) (17)
The impact of privacy protections on recruitment in a multicenter stroke genetics study (2005) (17)
Associations of Perioperative Variables With the 30-Day Risk of Stroke or Death in Carotid Endarterectomy for Symptomatic Carotid Stenosis. (2019) (16)
Behavioral symptoms in long-term survivors of ischemic stroke. (2010) (16)
Hippocampal progenitor cells express nestin following cerebral ischemia in rats (2005) (15)
Is Hemispheric Hypoperfusion a Treatable Cause of Cognitive Impairment? (2019) (15)
Carotid Stenting Versus Carotid Endarterectomy: What Did the Carotid Revascularization Endarterectomy Versus Stenting Trial Show and Where Do We Go From Here? (2017) (15)
Genomic Risk Profiling of Ischemic Stroke: Results of an International Genome-Wide Association Meta-Analysis (2011) (15)
Trials and Frontiers in Carotid Endarterectomy and Stenting. (2018) (14)
Agreement between site-reported and ultrasound core laboratory results for duplex ultrasound velocity measurements in the Carotid Revascularization Endarterectomy versus Stenting Trial. (2013) (13)
Regarding "Statement regarding carotid angioplasty and stenting". (1997) (13)
Prevention and management of medical complications of the hospitalized elderly stroke patient. (1991) (13)
Body mass index and outcome after revascularization for symptomatic carotid artery stenosis (2017) (13)
Management of Vascular Risk Factors in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) (2014) (13)
Carotid artery stenting versus carotid endarterectomy: current status. (2006) (12)
Image analysis and 3-D visualization of intracerebral brain hemorrhage (1993) (12)
Very early edema growth not significantly associated with neurologic deterioration in patients with intracerebral hemorrhage (1995) (12)
The Siblings With Ischemic Stroke Study (SWISS): a progress report. (2006) (12)
Interventions to Increase Enrollment in a Large Multicenter Phase 3 Trial of Carotid Stenting Vs. Endarterectomy (2012) (11)
Periprocedural Stroke and Myocardial Infarction as Risks for Long-Term Mortality in CREST (2017) (11)
Quality Assurance for Carotid Stenting in the CREST-2 Registry. (2019) (11)
Reperfusion therapy for acute ischemic stroke: how should we react to the Third Interventional Management of Stroke (IMS III) trial? (2013) (11)
Prediction Models for Clinical Outcome After a Carotid Revascularization Procedure (2018) (11)
New insights on thrombolytic treatment of acute ischemic stroke (2001) (10)
Impact of Restricting Enrollment in Stroke Genetics Research to Adults Able to Provide Informed Consent (2008) (10)
Abstract WP332: Updating the Structure of Stroke Clinical Research Data: Version 2 of the Stroke Common Data Elements From the National Institutes of Health/National Institute of Neurological Disorders and Stroke (2016) (10)
Outcomes after carotid endarterectomy among elderly dual Medicare-Medicaid–eligible patients (2018) (10)
Carotid Artery Stenting: JACC State-of-the-Art Review. (2022) (10)
Angioplasty and stenting should be performed only in the setting of a clinical trial. (2002) (10)
Sex differences in stroke evaluations in the Ischemic Stroke Genetics Study. (2007) (9)
Early Surgical Treatment for Supratentorial Intracerebral Hemorrhage (1999) (9)
Age and Outcomes following Stenting compared to Endarterectomy: The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) (2011) (9)
Thrombolytic therapy for cerebral infarction. (1996) (9)
Secular Trends in Procedural Stroke or Death Risks of Stenting Versus Endarterectomy for Symptomatic Carotid Stenosis. (2019) (9)
Challenge and Yield of Enrolling Racially and Ethnically Diverse Patient Populations in Low Event Rate Clinical Trials (2018) (9)
Duration of asymptomatic status and outcomes following carotid endarterectomy and carotid artery stenting in the Carotid Revascularization Endarterectomy vs Stenting Trial. (2019) (8)
Strategies for Early Treatment of Acute Cerebral Infarction (1991) (8)
Stroke Genetic Research and Adults With Impaired Decision-Making Capacity: A Survey of IRB and Investigator Practices (2008) (8)
Risk of Stroke before Revascularisation in Patients with Symptomatic Carotid Stenosis: A Pooled Analysis of Randomised Controlled Trials. (2021) (8)
Baseline Cognitive Impairment in Patients With Asymptomatic Carotid Stenosis in the CREST-2 Trial (2021) (8)
Factors influencing credentialing of interventionists in the CREST-2 trial. (2020) (8)
CREST: Carotid Revascularization Endarterectomy versus Stent Trial (1997) (8)
The CREST-2 experience with the evolving challenges of COVID-19 (2020) (8)
Pharmacotherapy for Patients With Atrial Fibrillation and Cerebral Microbleeds. (2019) (8)
Incidence Rates of Stroke for Blacks and Whites: Preliminary Results from the Greater Cincinnati/Northern Kentucky Stroke Study (2001) (8)
Safety of Carotid Revascularization in Patients With a History of Coronary Heart Disease (2019) (7)
Influence of multiple stents on periprocedural stroke after carotid artery stenting in the Carotid Revascularization Endarterectomy versus Stent Trial (CREST) (2019) (7)
Characteristics of participants consenting versus declining follow-up for up to 10 years in a randomized clinical trial (2015) (7)
Response to ethical challenges in stroke research (1998) (7)
141st Annual Meeting of the American Neurological Association (1996) (7)
Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial (2020) (7)
Genome-wide screen for stroke: Pilot testing in the Siblings With Ischemic Stroke Study (SWISS) (2000) (6)
Financial Management of a Large Multisite Randomized Clinical Trial (2014) (6)
Carotid artery stenting: a clinical update (2012) (6)
Creation of a Bilingual Spanish-English Version of the Questionnaire for Verifying Stroke-Free Status (2004) (6)
Stroke Council of the American Heart Association Intracranial Aneurysms : A Statement for Healthcare Professionals From the Recommendations for the Management of Patients With Unruptured (2009) (6)
Asymptomatic carotid stenosis (2017) (6)
Temporal Changes in Periprocedural Events in the Carotid Revascularization Endarterectomy Versus Stenting Trial (2015) (6)
Picking the Good Apples: Statistics Versus Good Judgment in Choosing Stent Operators for a Multicenter Clinical Trial (2014) (6)
Treatment of Carotid Stenosis in Asymptomatic, Non-Octogenarian, Standard Risk Patients with Stenting versus Endarterectomy Trials. (2021) (6)
Prevalence of Previously Undiagnosed Abdominal Aortic Aneurysms in Patients with Intracranial Aneurysms: From the Brain and Aortic Aneurysms Study (BAAS) (2019) (5)
Intracranial hemorrhage complicating carotid artery stenting and carotid endarterectomy. (2011) (5)
Carotid endarterectomy versus angioplasty/stenting for carotid stenosis (2007) (5)
Cerebrovascular Diseases: New Trends in Surgical and Medical Aspects edited by H.J.M. Barnett, P. Paoletti, E.S. Flamm and G. Brambilla, Elsevier/North-Holland Biomedical Press, 1981. Dfl. 170.00 (vii + 405 pages) ISBN 0 444 80381 5 (1982) (5)
Correlation of proband and sibling stroke latency: The SWISS Study (2005) (5)
Spouses and Unrelated Friends of Probands as Controls for Stroke Genetics Studies (2003) (5)
Transesophageal echocardiography in source-of-embolism evaluation: the search for a better therapeutic rationale. (1999) (5)
Haitians in Miami: An Assessment of Their Background and Potential (Dialogue #12) (1982) (5)
Mayo Acute Stroke Trial for Enhancing Recovery (MASTER) protocol. (2010) (5)
178 – Thrombolysis for Acute Ischemic Stroke (1997) (5)
SS11. Carotid Lesion Characteristics Are Major Factors Contributing to Treatment Difference in Periprocedural Stroke and Death Among Patients Undergoing Carotid Artery Stenting (CAS) and Carotid Endarterectomy (CEA) in the CREST Trial (2015) (5)
American Society for Stereotactic and Functional Neurosurgery Bestows Distinguished Service Award on Dr. med. h.c. mult. Thomas Karger and Prof. Dr. Phil Gildenberg (2003) (4)
Symptom-Based Trials of Intravenous rt-PA in Acute Stroke (1993) (4)
Haitians Released from Krome: Their Prospects for Adaptation and Integration in South Florida (Dialogue #24) (1984) (4)
Reopening occluded cerebral arteries (2003) (4)
Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis. (2020) (4)
Modern treatment options for intracerebral hemorrhage (2006) (4)
Factors Related to Intracranial Hematoma Formation in Patients Receiving t-PA for Acute Ischemic Stroke (1993) (4)
A Survey of the SWISS Researchers on the Impact of Sibling Privacy Protections on Pedigree Recruitment (2005) (4)
Non-Adherence to Antihypertensive Guidelines in Patients with Asymptomatic Carotid Stenosis. (2021) (3)
Enhancing the Informed Consent Process Using Shared Decision Making and Consent Refusal Data from the CLEAR III Trial (2020) (3)
Carotid surgery to prevent stroke (2004) (3)
Mitigating the effects of COVID-19 pandemic on controlling vascular risk factors among participants in a carotid stenosis trial (2020) (3)
Novel Approaches to Stroke Prevention in Atrial Fibrillation: Introduction (2007) (3)
Carotid Stenosis: to Revascularize, or Not to Revascularize: That is the Question (2012) (3)
Patent foramen ovale: friend or foe? (2003) (2)
Go Red for Women Does Sex Matter? Thirty-Day Stroke and Death Rates After Carotid Artery Stenting in Women Versus Men (2009) (2)
Evaluation of Tissue Plasminogen Activator Early in the Course of Acute Ischemic Stroke (1991) (2)
Restenosis after carotid endarterectomy and stenting – Authors' reply (2013) (2)
Of horse races, trials, meta-analyses, and carotid artery stenosis. (2011) (2)
Safety of the transradial approach to carotid stenting (2021) (2)
Management of Stenosis of the Extracranial Internal Carotid Artery: Endarterectomy Versus Angioplasty and Stenting (2010) (2)
Feasibility and Exploratory Efficacy Evaluation of the Embrella Embolic Deflector System for the Prevention ofCerebral Emboli in Patients Undergoing Transcatheter Aortic ValveReplacement (2)
Stroke: Warning signs and potential risk factors (1999) (2)
Race Differences in High-Grade Carotid Artery Stenosis (2021) (2)
Original Contributions Hypertension as a Risk Factor for Spontaneous Intracerebral Hemorrhage (1986) (2)
Factors Associated With Time to Site Activation, Randomization, and Enrollment Performance in a Stroke Prevention Trial (2017) (2)
Absence of Consistent Sex Differences in Outcomes From Symptomatic Carotid Endarterectomy and Stenting Randomized Trials. (2021) (2)
The Nurse Clinician: Role Conflict in Research (1993) (2)
Transatlantic Differences in Management of Carotid Stenosis: BRIDGing the Gap in StrokE Management (BRIDGE) Project (2018) (2)
Clinical, anatomic, and procedural durability of carotid revascularization. (2013) (2)
Planning genetic studies and human stroke: sample size estimates based on family history data. (2002) (2)
Parallel Hypothesis Testing for Science and Industry in a Large Randomized Clinical Trial (2001) (2)
Timing of procedural stroke and death in asymptomatic patients undergoing carotid endarterectomy: individual patient analysis from four RCTs (2019) (2)
Abstract 4: Angiographic Predictors of Stroke after Carotid Artery Stenting - A Qualitative and Quantitative Analysis of 1070 Patients in the Carotid Revascularization Endarterectomy versus Stenting Trial (2012) (2)
Abstract 15: Trends in Performance and Outcomes of Carotid Endarterectomy Among Elderly Medicare Beneficiaries, 2003-2010 (2016) (1)
Every physician should discourage cigarette smoking (2018) (1)
Abstract TMP10: A Retrospective Comparison of Medical Eligibility for Acute Ischemic Stroke Clinical Trials Compared with Hospital Enrollment Rates: Greater Cincinnati/Northern Kentucky Population (2016) (1)
An Analysis of Factors Associated with Early Intracerebral Hemorrhage (ICH) Growth (2001) (1)
[196] Ultra-early evaluation of intracerebral hemorrhage (1991) (1)
Carotid artery stenting versus carotid endarterectomy: current status. (2008) (1)
Thrombolytic Treatment of Patients with Acute Ischemic Stroke (1992) (1)
Stroke Symptoms as a Surrogate in Stroke Primary Prevention Trials (2022) (1)
Abstract 69: The Effect of Patching in Carotid Endarterectomy (CEA) on Reducing The Risk of Restenosis and Stroke in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) (2014) (1)
Safety and Efficacy of Intraventricular Delivery of Bone Marrow-Derived Mesenchymal Stem Cells in Hemorrhagic Stroke Model (2019) (1)
Degree of Stenosis by Angiography Does Not Influence Risk of Endarterectomy or Stenting in Patients with Severe Asymptomatic Carotid Stenosis (P1.236) (2016) (1)
Prevalence of Intracranial Aneurysms in Patients with Infrarenal Abdominal Aortic Aneurysms: A Multicenter Experience (2020) (1)
Higher Long-Term Mortality with Carotid Artery Stenting in Asymptomatic Male Compared with Female Patients in the Southeastern Vascular Study Group (2020) (1)
Thrombolysis for acute ischemic stroke: future directions. (2001) (1)
Intracerebral hemorrhage. (1993) (1)
Revascularization Risk in Symptomatic Versus Asymptomatic Patients – Relative Versus Absolute Risk: The Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) (S22.001) (2013) (1)
Incidence Rates of Ischemic Stroke in Diabetics: Preliminary Race-Specific Results from the Greater Cincinnati/Northern Kentucky Stroke Study (2001) (1)
Treatment of migraine in patients with CADASIL: A systematic review and meta-analysis. (2020) (1)
Thrombolytic therapy. (1992) (1)
Vertebral Artery Disease SVS Guideline on the Management of Patients With Extracranial Carotid and ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/ 2011 (2011) (1)
The Clinical Need , Design , and Goals for CREST-2 (2017) (1)
Angiographic Predictors of Stroke after Carotid Artery Stenting – A Qualitative and Quantitative Analysis of 1070 Patients in the Carotid Revascularization Endarterectomy Versus Stenting Trial (S09.002) (2012) (1)
Joint Commission primary stroke center certification does not affect proband enrollment: the siblings with ischemic stroke study. (2009) (1)
Carotid Artery Surgery to Reduce Long-Term Stroke Rates: Individual Patient Data Meta-Analysis of the Randomised Trials in Asymptomatic Patients (2021) (1)
Volume of First-Ever Ischemic Stroke Among Blacks in a Population-Based Study (2001) (1)
Silent cerebral infarction/lacunes. (1994) (1)
Capgras syndrome and minor head trauma (I: Reply) (1989) (1)
Abstract 1: Did Carotid Stenting and Endarterectomy Outcomes Change Over Time in the Carotid Revascularization Endarterectomy versus Stenting Trial? (2012) (1)
Lessons From ACST-2. (2022) (1)
Ascertainment of any and all neurologic and myocardial damage in carotid revascularization: the key to optimization? (2013) (1)
Association Scientific Statement From the Stroke Council of the American Stroke Guidelines for the Early Management of Patients With Ischemic Stroke: A (2007) (1)
Covid-19, Contrast, and CREST-2: A Survey of Investigators. (2022) (0)
Duration of Asymptomatic Status and Outcomes Following Endarterectomy and Stenting in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) (P1.237) (2016) (0)
Genome-wide Search for Ischemic Stroke Genes: The Siblings with Ischemic Stroke Study (SWISS) (2011) (0)
Abstract 8: Retinopathy is Associated With Stroke, Dementia, and Mortality (2021) (0)
When Will We Have What We Need to Advise Patients How to Manage Their Carotid Stenosis?: Lessons From SPACE-2 (2023) (0)
Abstract 17291: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis: CREST-2 update (2015) (0)
Risk of Stroke before Revascularisation in Patients with Symptomatic Carotid Stenosis: A Pooled Analysis of Randomised Controlled Trials (2021) (0)
Carotid Ar tery Stenting Versus Carotid Endar terectomy : Status (2008) (0)
Analysis of the age-at-onset phenotype in a pilot genome-wide association study of ischemic stroke (2008) (0)
No Sex Differences in the Prevalence of Intracranial Aneurysms in Patients with Ascending Thoracic Aortic Aneurysms: A Multi-Center Experience. (2023) (0)
Effect of Office-Based Ultrasonography on Adherence–Reply–I (2007) (0)
Abstract WP560: Cerebral Small Vessel Disease is Associated With Poor Collateral Recruitment in Large-Vessel Occlusive Stroke (2019) (0)
Abstract TP131: Carotid Stenosis and Polyvascular Disease (2020) (0)
Abstract WP172: Advancing Age is a Predictor of Poor Collaterals (2020) (0)
Abstract TP199: Association Between Left Atrial Enlargement and Poor Collaterals in Large Vessel Occlusion (2020) (0)
Contributions Hypertension as a Risk Factor for Spontaneous Intracerebral Hemorrhage (2005) (0)
Prehospital Management of Stroke Patients (1997) (0)
Abstract P20: One-Year Hospitalization Costs Associated with Carotid Stenting Versus Endarterectomy: Results from the CREST Trial (2011) (0)
Abstract MP44: Sex and Outcomes After Carotid Stenting and Endarterectomy for Asymptomatic Patients: A Pooled Analysis of the Crest and Act I Trials (2021) (0)
Abstract 70: Age and Outcomes After Carotid Stenting and Endarterectomy: A Pooled Analysis of the Crest and Act I Trials (2020) (0)
Risk Factors for Misdiagnosis of Subarachnoid and Intracerebral Hemorrhage (2001) (0)
Duplex velocity criteria for carotid endarterectomy. (2017) (0)
Low Risk of Stroke or Death among Patients with Recently Symptomatic Carotid Stenosis Awaiting Revascularization—A Pooled Analysis of Recent Randomized Trials (2015) (0)
The Challenge of Preventing Carotid Artery Stroke in Properly Medically Managed Patients: Lessons From SPACE-2. (2023) (0)
Abstract WMP112: Cilostazol versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis (2020) (0)
CENTRALIZED COGNITIVE ASSESSMENT IN A MULTICENTER TRIAL OF TREATMENT MODES FOR ASYMPTOMATIC CAROTID ARTERY DISEASE (2018) (0)
Health Screening Program to Enhance Enrollment of Women and Minorities in CREST-2 (2022) (0)
Treatment of carotid stenosis in asymptomatic, non-octogenarian, standard risk patients with stenting versus endarterectomy trials (2022) (0)
Results of NOTCH3 Sequencing in Siblings with Ischemic Stroke Study Probands (2011) (0)
758 Stroke March 2015 restenosis , and potentially reduce the risk of postoperative ipsilateral stroke (0)
Long-ternm outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a meta-analysis of Individual patient data (2014) (0)
Stroke: Intervention in carotid stenosis—is the issue resolved? (2010) (0)
The Heart and Stroke (1988) (0)
Neurohospitalist Medicine: Cerebrovascular disease: ischemic (2011) (0)
DURABILITY OF REVASCULARIZATION 219 Restenosis after CEA : Vascular Biology and Technical Considerations (0)
Contents to volume 17 (2004) (0)
Abstract P564: Hypertriglyceridemia as a Treatment Target in Asymptomatic Carotid Stenosis (2021) (0)
, Versus Stenting Trial ( CREST ) Standard Surgical Risk : Results From the Carotid Revascularization Endarterectomy Costs and Cost-Effectiveness of Carotid Stenting Versus Endarterectomy for Patients at (2012) (0)
Abstract WP148: The BRIDGE Project ( BRIDG ing the gap in strok E management):Trans-Atlantic Differences in Management of Carotid Stenosis (2013) (0)
Proband race/ethnicity affects pedigree completion rate in a genetic study of ischemic stroke. (2008) (0)
Mesenchymal stem cells facilitate neuron recovery after oxygen-glucose deprivation injury (2013) (0)
Abstract TP132: Selection and Activation of Sites in a Large Multi-Center Randomized Clinical Trial (2017) (0)
Abstract W P310: National Trends in Carotid Artery Stenting and Endarterectomy by Sex, Race, and Region: 2007-2011 (2014) (0)
Abstract 3686: Stroke, TIA, Amaurosis Fugax, or No Symptoms as Predictors of Outcomes in the Carotid Revascularization Endarterectomy versus Stenting Trial (2012) (0)
Abstract TMP34: The Challenge and Yield of Racially and Ethnically Diverse Patient Populations in Low Event-Rate Clinical Trials (2017) (0)
Ischemic Stroke Mechanism and Likelihood of Having a Positive Family History of Stroke (2001) (0)
Abstract 84: Low Risk of Stroke or Death Among Patients With Recently Symptomatic Carotid Stenosis Awaiting Revascularisation - A Pooled Analysis of Randomised Trials (2014) (0)
Effect of office-based ultrasonography on adherence. Authors' reply (2007) (0)
Abstract WMP76: Carotid Revascularization Slows Hemispheric White Matter Disease Progression (2023) (0)
Failure to Wean from a Ventilator Caused by ANNA-1 Seropositive Paraneoplastic Syndrome (2003) (0)
Asymptomatic Females Are at Higher Risk for Perioperative TIA/Stroke and Males Are at Higher Risk for Long-Term Mortality after Carotid Artery Stenting: A Vascular Quality Initiative Analysis (2020) (0)
Abstract TMP24: Duration of Asymptomatic Status and Outcomes Following Endarterectomy and Stenting in the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) (2016) (0)
Abstract TP131: Degree of Stenosis by Angiography Does not Influence Risk of Endarterectomy or Stenting in Patients With Severe Asymptomatic Carotid Stenosis (2016) (0)
Abstract 6: Relationship between Center-Volume and Complication Rates in the Carotid Revascularization Endarterectomy versus Stenting Trial (2012) (0)
Abstract TP129: Revascularization Risk in Symptomatic versus Asymptomatic Patients - Relative versus Absolute Risk: The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) (2013) (0)
Abstract TP137: Relationship Between Risk Factor Control and Physician Specialty in the CREST2 Trial (2018) (0)
Higher Degree of Carotid Artery Stenosis is Associated with Worse Cognition (S45.005) (2023) (0)
Trends in Carotid Revascularization Procedures-Reply. (2018) (0)
Clinical Practice Statement : Tissue Plasminogen Activator ( tPA ) and Stroke : A Clinical Practice Advisory (2010) (0)
Metro Stroke Task Force Survey of Resources for Diagnosis of Non-Traumatic Subarachnoid Hemorrhage (2000) (0)
With Thrombolysis for Acute Stroke (1997) (0)
Abstract 69: Can Patient or Arterial Characteristics Guide the Choice between Carotid Angioplasty and Carotid Endarterectomy? The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) (2013) (0)
Intracerebral Hemorrhage Progression (1998) (0)
Emberson, J. et al. (2014) Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data (2014) (0)
Risk-stratified imputation in survival analysis (2013) (0)
Adapting to Evolving Technologies and Treatment Guidelines in a Procedural Trial: A Qualitative Review of the CREST-2 Experience. (2023) (0)
Carotid Plaque Characterization In A Large Randomized Trial: Results From CREST-2 (2018) (0)
Genetic variation in the phosphodiesterase 4D gene is associated with ischemic stroke severity: The ISGS study (2007) (0)
Cranial Nerve Injury (CNI) in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): Incidence, Outcomes and Quality of Life (2014) (0)
E-077 Carotid ultrasound findings and stenosis severity at enrollment in CREST 2 (2022) (0)
Did Carotid Stenting and Endarterectomy Outcomes Change over Time in the Carotid Revascularization Endarterectomy Versus Stenting Trial? (S09.005) (2012) (0)
Surgical prevention of stroke (2013) (0)
Contributions Initial and Recurrent Bleeding Are the Major Causes of Death Following Subarachnoid Hemorrhage (2005) (0)
Stroke Care 2006: Clinical Consensus and Opportunities Stroke Care After the 3 Hour Window for IV tPA use: What Diagnostic and Therapeutic Options? (2006) (0)
Oral contraceptives and stroke risk: the debate continues (2004) (0)
Patients Consenting to or Declining Extended Follow-up (Up to Ten Years) in the Carotid Revascularization Endarterectomy (CEA) versus Stenting (CAS) Trial (CREST) (P2.268) (2015) (0)
The following is in response: To the editor (1992) (0)
Abstract WP403: Trends and Predictors of Intracranial Hemorrhage in Patients With Advanced Heart Failure on Left Ventricular Assist Device From 2005 to 2014 in the U.S. (2020) (0)
Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis (2019) (0)
Abstract TMP81: The Relationship Between Carotid Stenosis And Silent Cerebrovascular Disease (2022) (0)
Abstract 3: Restenosis following Carotid Artery Stenting and Endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (2012) (0)
Mediators of the Age Effect among Patients Treated with Carotid Artery Stenting: The Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) (P02.017) (2013) (0)
Abstract TP527: Baseline Physical Activity Profiles in CREST-2 Trial Participants (2019) (0)
Stroke, TIA, Amaurosis Fugax, or No Symptoms as Predictors of Outcomes in the Carotid Revascularization Endarterectomy Versus Stenting Trial (S09.001) (2012) (0)
Abstract TP338: Outcomes After Carotid Endarterectomy Among Dual-eligible Medicare-Medicaid Beneficiaries, 2003-2010 (2016) (0)
Intracerebral Hemorrhage: Foreword by Thomas Brott (2009) (0)
Selected Abstracts from the January Issue of the Journal of Vascular Surgery (2014) (0)
Restenosis Following Carotid Artery Stenting and Endarterectomy in the Carotid Revascularization Endarterectomy Versus Stenting Trial (IN2-1.001) (2012) (0)
Duplex Ultrasound Velocity Criteria to Determine Carotid Artery Stenosis Need to Be Revised: Results from CREST (2020) (0)
SELECTION AND ACTIVATION OF SITES IN A LARGE MULTI-CENTER RANDOMIZED CLINICAL TRIAL (P6.280) (2017) (0)
Edinburgh Research Explorer Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke (2017) (0)
Duration of Asymptomatic Status and Outcomes Following Carotid Endarterectomy and Carotid Artery Stenting in CREST (2017) (0)
Framingham Risk Score and White Matter Disease Progression (P11-5.009) (2023) (0)
Abstract W MP108: Accuracy of Diagnoses in Contemporary Medicare Data: REGARDS Study Linked With Medicare Claims (2014) (0)
2011 ASA/ACCF/AHA/AANN/AAN S/ACR/ASNR/CN S/SAIP/ patients with extracranial carotid and vertebral artery disease (2013) (0)
Relationship between Center-Volume and Complication Rates in the Carotid Revascularization Endarterectomy Versus Stenting Trial (P06.204) (2012) (0)
Abstract TMP96: Carotid Plaque Characteristics Correlated to Baseline Vascular Risk Factors in a Large Randomized Trial: Results from CREST-2 (2019) (0)
Abstract TP124: Mediators of the Age Effect among Patients Treated with Carotid Artery Stenting: The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) (2013) (0)
Abstract TP141: Can the Human Eye Match a Computer Algorithm in Identifying Hypoperfusion in Asymptomatic Carotid Artery Stenosis? (2020) (0)
Table 1: Ich Primary and Edema Region Volumes View 1 View 2 View 3 View 4 Figure 2: Ich Primary Region Visualization. 8 Conclusion and Further Work (1993) (0)
A Post-Hoc Assessment of Current Hormone Therapy on Revascularization Risk in Women: The Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) (P03.168) (2013) (0)
Carotid Artery Disease and Stroke: Natural History and Medical Therapy (1997) (0)
Cortical Thinning in High-Grade Asymptomatic Carotid Stenosis (2023) (0)
Abstract TP123: Baseline Differences in Risk Factor Control Between CREST-2 and SAMMPRIS (2020) (0)
Early treatment of acute ischemic stroke. (1991) (0)
Abstract WMP41: Predictors of Poor Collaterals in Large-Vessel Occlusive Stroke (2019) (0)
Abstract TP135: Control of Vascular Risk Factors at Baseline in CREST-2 (2018) (0)
Emergency Medical Services (EMS)Response and Transport Time for Stroke in an Urban African-American Population: Effect of Socio-demographics of the Patient’s ZIP Code (2000) (0)
Abstract 14735: Carotid Artery Stenting and Carotid Endarterectomy are Comparable Among Medicare Beneficiaries Treated in Routine Clinical Practice (2014) (0)
Effects of alteplase for acute stroke according to criteria defining the EU and US marketing authorizations: individual-patient-data meta-analysis of randomized trials (2017) (0)
Stenting versus Surgery for Carotid Stenosis. (2016) (0)
Stroke Progress Review Group: looking back and going forward: introduction. (2013) (0)
Abstract 189: Analysis of Hypertension Associated Genetic Variants in Stroke Cases and Controls (2012) (0)
Abstract WP176: Recanalization of Chronically Occluded Internal Carotid Artery (2019) (0)
Improving practice through neurovascular board (2017) (0)
Abstract 42: CAS versus CEA Treatment Differences in Long-Term Outcomes and Post-Procedural Durability: the Carotid Stenosis Trialist Collaboration (CSTC) (2019) (0)
Ischemic Stroke? Associated Single-Nucleotide Polymorphisms Associated With - Are Myocardial Infarction (2012) (0)
Abstract WP160: A Post-Hoc Assessment of Current Hormone Therapy on Revascularization Risk in Women: The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) (2013) (0)
Can Patient or Arterial Characteristics Guide the Choice between Carotid Angioplasty and Carotid Endarterectomy? The Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) (P01.225) (2013) (0)
Early carotid surgery versus stenting in younger patients – Authors' reply (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Thomas G. Brott?

Thomas G. Brott is affiliated with the following schools:

Thomas G. Brott's Academic­Influence.com Rankings

Why Is Thomas G. Brott Influential?

Thomas G. Brott's Published Works

Published Works

What Schools Are Affiliated With Thomas G. Brott?

Thomas G. Brott's AcademicInfluence.com Rankings